ID   KDH-8
AC   CVCL_HX29
DR   Wikidata; Q54899707
RX   PubMed=8635193;
RX   PubMed=12192538;
CC   Transformant: ChEBI; CHEBI_76329; 3'-methyl-4-dimethylaminoazobenzene (3'-Me-DAB).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Wistar King Aptekman/Hok (WKA/Hok); RS=RS_0001595.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 8
//
RX   PubMed=8635193; DOI=10.1007/BF01526555; PMCID=PMC11037597;
RA   Yuan, Lan
RA   Kuramitsu, Yasuhiro
RA   Li, Yong-Qin
RA   Kobayashi, Masanobu
RA   Hosokawa, Masuo
RT   "Restoration of interleukin-2 production in tumor-bearing rats through
RT   reducing tumor-derived transforming growth factor beta by treatment
RT   with bleomycin.";
RL   Cancer Immunol. Immunother. 41:355-362(1995).
//
RX   PubMed=12192538; DOI=10.1007/s00262-002-0290-6; PMCID=PMC11032990;
RA   Zhao, Wen-Li
RA   Kobayashi, Masanobu
RA   Ding, Wei
RA   Yuan, Lan
RA   Seth, Prem
RA   Cornain, Santoso
RA   Wang, Jing-Xin
RA   Okada, Futoshi
RA   Hosokawa, Masuo
RT   "Suppression of in vivo tumorigenicity of rat hepatoma cell line KDH-8
RT   cells by soluble TGF-beta receptor type II.";
RL   Cancer Immunol. Immunother. 51:381-388(2002).
//